Insider · CIK 0001938146
Hannah Fry
Files at TARA (Protara Therapeutics, Inc.). First filing -, latest -.
In brief
Hannah Fry files SEC Form 4 as officer at TARA (Protara Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Hannah Fry has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | TARA Protara Therapeutics, Inc. | FTax withholding Common Stock | -1,457 | $6.67 | $9,718 | 42,723 | Jan 27, 2026 |
| Jan 20, 2026 | TARA Protara Therapeutics, Inc. | FTax withholding Common Stock | -2,132 | $5.60 | $12k | 44,180 | Jan 22, 2026 |
| Jan 16, 2026 | TARA Protara Therapeutics, Inc. | AGrant or award Common Stock | +9,500 | $0.00 | $0 | 46,312 | Jan 21, 2026 |
| Jan 16, 2026 | TARA Protara Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +55,000 | $0.00 | $0 | 55,000 | Jan 21, 2026 |
| Jan 24, 2025 | TARA Protara Therapeutics, Inc. | AGrant or award Common Stock | +9,500 | $0.00 | $0 | 38,942 | Jan 28, 2025 |
| Jan 24, 2025 | TARA Protara Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +55,000 | $0.00 | $0 | 55,000 | Jan 28, 2025 |
| Jan 21, 2025 | TARA Protara Therapeutics, Inc. | FTax withholding Common Stock | -2,130 | $4.76 | $10k | 27,312 | Jan 23, 2025 |
| Jan 3, 2025 | TARA Protara Therapeutics, Inc. | FTax withholding Common Stock | -394 | $6.14 | $2,419 | 29,442 | Jan 7, 2025 |
| Jan 19, 2024 | TARA Protara Therapeutics, Inc. | AGrant or award Common Stock | +8,000 | $0.00 | $0 | 30,740 | Jan 23, 2024 |
| Jan 19, 2024 | TARA Protara Therapeutics, Inc. | FTax withholding Common Stock | -904 | $1.91 | $1,727 | 29,836 | Jan 23, 2024 |
| Jan 19, 2024 | TARA Protara Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +46,000 | $0.00 | $0 | 46,000 | Jan 23, 2024 |
| Jan 3, 2024 | TARA Protara Therapeutics, Inc. | FTax withholding Common Stock | -324 | $2.17 | $703 | 22,740 | Jan 5, 2024 |
Questions about Hannah Fry
Answered from the filings on this page, as of the latest one.
Is Hannah Fry buying or selling?
Hannah Fry has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Hannah Fry's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Hannah Fry has 0.
Where does Hannah Fry file Form 4?
Hannah Fry has filed Form 4 at TARA (Protara Therapeutics, Inc.) as VP, Controller. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.